Alembic Pharmaceuticals Ltd Share Price

Overview

Alembic Pharmaceuticals Ltd share price is currently ₹803.62, down by - ₹10.95 (1.34%) from its previous closing price of ₹814.57. The share price has gained 2.72% over the past month and declined -14.7% over the past year. The stock's 52-week low and high are ₹626.30 and ₹993.45, respectively. Alembic Pharmaceuticals Ltd has a market capitalisation of ₹ 16,150.00 Cr. The share price was last updated on 24 Aug 2026, 03:58 PM IST.

Alembic Pharmaceuticals Ltd

APLLTD

₹0.00

- ₹10.95

1.34%

Healthcare

₹0.00(%)1D

Updated: 24 Aug 2026, 03:58:26 pm IST

Market Data

Open Price

₹800.84

Prev. Close

₹814.57

₹798.81

Day Low

₹812.90

Day High

₹626.30

52 Week Low

₹993.45

52 Week High

HealthcarePharmaceuticals & Drugs

CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

22.78

Sector PE

42.03

PB Ratio

2.78

Sector PB

5.82

EPS

35.28

Dividend Yield

1.81

Today's Volume

39.974 K

5 Day Avg. Volume

54.457 K

PEG Ratio

1.45

Market Cap.

₹ 16,150.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

Actions	Ex-Date	Record-Date
DividendsFinal Dividend of 600% at ₹12/Share	29-Jul-2026	29-Jul-2026
DividendsFinal Dividend of 550% at ₹11/Share	29-Jul-2025	29-Jul-2025

Mutual Fund Ownership

Mutual Fund Holder	Jun 26 Shares held	Jul 26 Shares held
Kotak Small Cap Fund - Growth	34.28 Lac	34.28 Lac no change
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth	20.77 Lac	20.77 Lac no change
DSP Small Cap Fund - Regular Plan - Growth	15.00 Lac	15.00 Lac no change
Axis Small Cap Fund - Regular Plan - Growth	14.55 Lac	14.55 Lac no change
DSP Healthcare Fund - Regular Plan - Growth	14.43 Lac	14.43 Lac no change

Show all holdings

About Alembic Pharmaceuticals Ltd 👋

Alembic Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing and marketing Indian Formulations, International Generics, and Active Pharmaceutical Ingredients (APIs) across the globe. It delivers a diverse and expanding range of generics across chronic segments. Its therapies include Dermatology, Anti-Infective, Cold & Cough, Gastrology, Cardiology, Anti-Diabetic, Ophthalmology, Nephro/Uro, Animal Health, Orthopedic and Gynecology. Its products under International Generics are manufactured across its facilities in Panelav, Karkhadi and Jarod in Gujarat. It also has research and development facilities in Vadodara (Gujarat), Hyderabad (Telangana), and New Jersey (United States). Its APIs are manufactured at its three plants in Panelav and Karkhadi in Gujarat. The manufacturing facility in Sikkim is for manufacturing its Indian Formulations.